COVID-19 Impairs Immune Response to Candida albicans
COVID-19는 Candida albicans에 대한 면역 반응을 손상시킵니다
Immunology
[키워드] abrogated
Activation
acute respiratory distress
acute respiratory distress syndrome
Antigen
ARDS
Aspergillus fumigatus
Blood
Candida
Candida albican
Candida albicans
CD244
CD38
CD4
CD8
CD80
changes in
characterization
characterized
clinical parameter
Clinical parameters
coronavirus
coronavirus disease
coronavirus disease-2019
COVID-19
COVID-19 patient
COVID-19 patients
Critically ill
critically ill COVID-19 patients
cytokine
cytokine release
Cytokines
cytokines IL-6
detrimental
elevated
fungal
healthy controls
HLA-DR
ICU
ICU admission
IL-10
IL-1α
IL-1β
IL-6
IL-8
Immune phenotype
immune response
Infection
lipopolysaccharide
Listeria monocytogene
Listeria monocytogenes
LPS
Lymphocytes
marker
monocyte
Monocyte activation
not differ
Pathogenesis
PD-1
plasma
Prognosis
recent
respiratory distress
response
SARS-CoV-2
second hit
Secondary infection
secondary infections
severe acute respiratory distress syndrome
susceptibility
syndrome
T cells
therapy
TNF
upregulation
were assessed
were used
yeast
[DOI] 10.3389/fimmu.2021.640644 PMC 바로가기 [Article Type] Immunology
[DOI] 10.3389/fimmu.2021.640644 PMC 바로가기 [Article Type] Immunology